HUT64217A - Process for producing solide dosing forms of almocalant - Google Patents
Process for producing solide dosing forms of almocalant Download PDFInfo
- Publication number
- HUT64217A HUT64217A HU9301670A HU167093A HUT64217A HU T64217 A HUT64217 A HU T64217A HU 9301670 A HU9301670 A HU 9301670A HU 167093 A HU167093 A HU 167093A HU T64217 A HUT64217 A HU T64217A
- Authority
- HU
- Hungary
- Prior art keywords
- tablets
- dosage form
- tablet
- pss
- prepared
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Chemical Treatment Of Metals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9003902A SE9003902D0 (sv) | 1990-12-07 | 1990-12-07 | Solid dosage forms of a drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9301670D0 HU9301670D0 (en) | 1993-09-28 |
| HUT64217A true HUT64217A (en) | 1993-12-28 |
Family
ID=20381121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9301670A HUT64217A (en) | 1990-12-07 | 1991-12-03 | Process for producing solide dosing forms of almocalant |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP0560821A1 (es) |
| JP (1) | JPH06503312A (es) |
| CN (1) | CN1063039A (es) |
| AP (1) | AP258A (es) |
| AU (1) | AU8930791A (es) |
| BG (1) | BG97851A (es) |
| CA (1) | CA2097178A1 (es) |
| CZ (1) | CZ103793A3 (es) |
| FI (1) | FI932554A7 (es) |
| HU (1) | HUT64217A (es) |
| IE (1) | IE914137A1 (es) |
| IL (1) | IL100150A0 (es) |
| IS (1) | IS3788A7 (es) |
| LT (1) | LTIP1717A (es) |
| MA (1) | MA22355A1 (es) |
| MX (1) | MX9102325A (es) |
| MY (1) | MY106776A (es) |
| NO (1) | NO932052D0 (es) |
| NZ (1) | NZ240731A (es) |
| PT (1) | PT99719A (es) |
| SE (1) | SE9003902D0 (es) |
| SK (1) | SK55693A3 (es) |
| TN (1) | TNSN91117A1 (es) |
| TW (1) | TW215057B (es) |
| WO (1) | WO1992010172A1 (es) |
| YU (1) | YU186891A (es) |
| ZA (1) | ZA919264B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19602757A1 (de) * | 1996-01-26 | 1997-07-31 | Boehringer Mannheim Gmbh | Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung |
| GB9611328D0 (en) * | 1996-05-31 | 1996-08-07 | Zeneca Ltd | Pharmaceutical compositions |
| US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
| JP4504467B2 (ja) * | 1998-07-30 | 2010-07-14 | 佐藤製薬株式会社 | 口腔内崩壊性錠剤 |
| JP7426685B2 (ja) * | 2018-06-14 | 2024-02-02 | 株式会社東洋新薬 | 錠剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8705150D0 (sv) * | 1987-12-23 | 1987-12-23 | Haessle Ab | Novel antiarrhythmic agents |
| IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it |
| SE8902236D0 (sv) * | 1989-06-20 | 1989-06-20 | Haessle Ab | Novel polystyrenesulfonate |
-
1990
- 1990-12-07 SE SE9003902A patent/SE9003902D0/xx unknown
-
1991
- 1991-11-22 ZA ZA919264A patent/ZA919264B/xx unknown
- 1991-11-25 IL IL100150A patent/IL100150A0/xx unknown
- 1991-11-25 TW TW080109239A patent/TW215057B/zh active
- 1991-11-26 NZ NZ240731A patent/NZ240731A/en unknown
- 1991-11-27 YU YU186891A patent/YU186891A/sh unknown
- 1991-11-28 IE IE413791A patent/IE914137A1/en unknown
- 1991-12-02 AP APAP/P/1991/000338A patent/AP258A/en active
- 1991-12-02 MX MX9102325A patent/MX9102325A/es unknown
- 1991-12-03 HU HU9301670A patent/HUT64217A/hu unknown
- 1991-12-03 SK SK55693A patent/SK55693A3/sk unknown
- 1991-12-03 AU AU89307/91A patent/AU8930791A/en not_active Abandoned
- 1991-12-03 EP EP91920708A patent/EP0560821A1/en not_active Withdrawn
- 1991-12-03 MA MA22639A patent/MA22355A1/fr unknown
- 1991-12-03 JP JP4500117A patent/JPH06503312A/ja active Pending
- 1991-12-03 FI FI932554A patent/FI932554A7/fi not_active Application Discontinuation
- 1991-12-03 CZ CS931037A patent/CZ103793A3/cs unknown
- 1991-12-03 WO PCT/SE1991/000815 patent/WO1992010172A1/en not_active Ceased
- 1991-12-03 CA CA002097178A patent/CA2097178A1/en not_active Abandoned
- 1991-12-06 IS IS3788A patent/IS3788A7/is unknown
- 1991-12-06 PT PT99719A patent/PT99719A/pt not_active Application Discontinuation
- 1991-12-06 TN TNTNSN91117A patent/TNSN91117A1/fr unknown
- 1991-12-06 MY MYPI91002267A patent/MY106776A/en unknown
- 1991-12-07 CN CN91112789A patent/CN1063039A/zh active Pending
-
1993
- 1993-06-04 BG BG97851A patent/BG97851A/xx unknown
- 1993-06-04 NO NO932052A patent/NO932052D0/no unknown
- 1993-12-30 LT LTIP1717A patent/LTIP1717A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU8930791A (en) | 1992-07-08 |
| HU9301670D0 (en) | 1993-09-28 |
| IE914137A1 (en) | 1992-06-17 |
| NZ240731A (en) | 1993-10-26 |
| ZA919264B (en) | 1992-08-26 |
| PT99719A (pt) | 1992-10-30 |
| IS3788A7 (is) | 1992-06-08 |
| LTIP1717A (en) | 1995-07-25 |
| EP0560821A1 (en) | 1993-09-22 |
| BG97851A (en) | 1994-04-29 |
| YU186891A (sh) | 1994-04-05 |
| WO1992010172A1 (en) | 1992-06-25 |
| FI932554L (fi) | 1993-06-08 |
| MY106776A (en) | 1995-07-31 |
| NO932052L (no) | 1993-06-04 |
| MA22355A1 (fr) | 1992-07-01 |
| MX9102325A (es) | 1992-06-01 |
| AP9100338A0 (en) | 1992-01-31 |
| JPH06503312A (ja) | 1994-04-14 |
| CA2097178A1 (en) | 1992-06-08 |
| IL100150A0 (en) | 1992-08-18 |
| CN1063039A (zh) | 1992-07-29 |
| SK55693A3 (en) | 1993-10-06 |
| FI932554A7 (fi) | 1993-06-08 |
| TNSN91117A1 (fr) | 1992-10-25 |
| AP258A (en) | 1993-06-03 |
| TW215057B (es) | 1993-10-21 |
| NO932052D0 (no) | 1993-06-04 |
| CZ103793A3 (en) | 1994-02-16 |
| SE9003902D0 (sv) | 1990-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5900425A (en) | Pharmaceutical preparations having controlled release of active compound and processes for their preparation | |
| RU2391115C2 (ru) | Композиции и способы стабилизации активных фармацевтических ингредиентов | |
| JP3488475B2 (ja) | 活性物質の増大した溶解速度を有する薬剤組成物類の調製方法、および得られた組成物類 | |
| US5972381A (en) | Solid solution of an antifungal agent with enhanced bioavailability | |
| KR20050083816A (ko) | 24시간 효능의 서방 트라마돌 조성물 | |
| RU2300368C2 (ru) | Содержащая ибупрофен композиция | |
| US7749536B2 (en) | Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture | |
| ZA200404467B (en) | 5HT4 Partial Agonist Pharmaceutical Compositions | |
| AU759517B2 (en) | Compositions comprising cefuroxime axetil | |
| KR20050043765A (ko) | 방출 제어형 메트포르민 정제 | |
| CZ124497A3 (en) | Oral preparations with prolonged release of cisaprid | |
| JP2016117738A (ja) | シロドシン−シクロデキストリン包接化合物 | |
| US5149523A (en) | Polystyrenesulfonate-drug complex and solid dosage forms thereof | |
| HUT64217A (en) | Process for producing solide dosing forms of almocalant | |
| EP0266707B1 (en) | Sustained release labetalol tablet | |
| US4940580A (en) | Sustained release labetalol tablets | |
| EP1458384A1 (en) | Amlopidine bezylate tablets with improved stability | |
| CZ20003779A3 (en) | Stable preparations containing levosimendan and alginic acid | |
| US20050042279A1 (en) | Pharmaceutical formulation comprising more than 15% tamoxifen | |
| JP3232687B2 (ja) | イミダプリル含有製剤 | |
| EP1889629B1 (en) | Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof | |
| KR100689862B1 (ko) | 말레인산암로디핀을 포함하는 조성물 및 그의 제조 방법 | |
| RU2190397C1 (ru) | Фармацевтическая композиция, содержащая кардиоселективный бета-адреноблокатор, и способ ее получения | |
| US20060177501A1 (en) | Film Coated Tablets Containing Ibuprofen | |
| JP2009542806A (ja) | 感湿性薬物及び第２薬物の組合せを含んで成る安定製剤及びその製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFD9 | Temporary protection cancelled due to non-payment of fee |